Pages that link to "Q993607"
Jump to navigation
Jump to search
The following pages link to Bruno Müller-Oerlinghausen (Q993607):
Displaying 50 items.
- (Q19593818) (← links)
- Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system (Q28191185) (← links)
- Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial (Q28259736) (← links)
- Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression (Q33645634) (← links)
- The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. (Q34230095) (← links)
- Commentary on a recent review of lithium toxicity: what are its implications for clinical practice? (Q34465856) (← links)
- Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients (Q34504598) (← links)
- Suicidality, impulsivity and aggression--is there a link to 5HIAA concentration in the cerebrospinal fluid? (Q35017840) (← links)
- The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. (Q35236618) (← links)
- Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder (Q35924815) (← links)
- Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. (Q36037459) (← links)
- The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients. (Q36195205) (← links)
- A critical appraisal of lithium's efficacy and effectiveness: the last 60 years (Q37524479) (← links)
- Lithium reduces pathological aggression and suicidality: a mini-review (Q37746783) (← links)
- Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters (Q38799039) (← links)
- Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behavior (Q42165870) (← links)
- Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder (Q42167248) (← links)
- Correspondence (letter to the editor): Cooperation of all participating groups (Q42431523) (← links)
- Heterogeneity of the risk of suicidal behavior in bipolar-spectrum disorders (Q42622821) (← links)
- Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders. (Q42678231) (← links)
- Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project (Q42918012) (← links)
- Some additional points (Q43119539) (← links)
- Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism (Q43843782) (← links)
- Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter (Q43938281) (← links)
- How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression. (Q44097699) (← links)
- The influence of successful prophylactic drug treatment on cognitive dysfunction in bipolar disorders (Q44110911) (← links)
- Low CSF 5-HIAA level in high-lethality suicide attempters: fact or artifact? (Q44123623) (← links)
- Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression (Q44133502) (← links)
- Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders (Q44177820) (← links)
- Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression (Q44309148) (← links)
- High platelet-serotonin uptake activity is associated with a rapid response in depressed patients treated with amitriptyline (Q44487762) (← links)
- Platelet-5HT uptake and gastrointestinal symptoms in patients suffering from major depression. (Q44650219) (← links)
- Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up (Q44801061) (← links)
- Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features (Q46233502) (← links)
- A multicenter study about Neurobiology of Suicidal Behavior: design, development, and preliminary results (Q46615993) (← links)
- Suicide prevention by lithium SUPLI--challenges of a multi-center prospective study (Q46615999) (← links)
- Insights in the central serotonergic function in patients with affective disorders (Q46670399) (← links)
- Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective disorders (Q47298019) (← links)
- Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: results of a 2-year observational algorithm study (Q48649196) (← links)
- [The efficacy of Slow Stroke Massage in depression]. (Q51970342) (← links)
- [Improving drug safety in Germany: an alliance between the government and the medical profession]. (Q52912793) (← links)
- [Pharmacological suicide prevention under special consideration of lithium salts]. (Q52922588) (← links)
- [Which evaluations are fundamental for medical training in pharmacotherapy?]. (Q52937452) (← links)
- The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. (Q52954955) (← links)
- Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders. (Q53171211) (← links)
- Lithium Clinics in Berlin and Dresden: a 50-Year Experience (Q56966165) (← links)
- Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project (Q57123926) (← links)
- MOGENS SCHOU: 100th anniversary of his birth (Q59805916) (← links)
- Long-Term Effectiveness of Lithium in Bipolar Disorder (Q61875908) (← links)
- [Pharmacologic management of atrial fibrillation by specialists in internal medicine, cardiologists, and general practitioners (GPs) in Berlin] (Q73851445) (← links)